 | • レポートコード：D0GIR-02356 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血管腫の世界市場を広く調査・分析し、今後の市場展望をまとめております。血管腫の種類別市場規模（医療、レーザー治療、外科、その他）、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Akrimax、Cutting Edge Laser Technologies、AstraZeneca、Novartis、Pierre Fabre、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・血管腫の北米市場（アメリカ、カナダ、メキシコ） ・血管腫のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血管腫のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血管腫の南米市場（ブラジル、アルゼンチン） ・血管腫の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：医療、レーザー治療、外科、その他 ・用途別分析：大人、子供 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Hemangioma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Hemangioma sales will be xx in 2020 from Hemangioma million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Hemangioma market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Hemangioma industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Hemangioma and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Hemangioma market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hemangioma market has been segmented into:
Medical Therapy
Laser Therapy
Surgery
Other
By Application, Hemangioma has been segmented into:
Adult
Child
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hemangioma market presented in the report. This section sheds light on the sales growth of different regional and country-level Hemangioma markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hemangioma market.
The report offers in-depth assessment of the growth and other aspects of the Hemangioma market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hemangioma Market Share Analysis
Hemangioma competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hemangioma sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hemangioma sales, revenue and market share for each player covered in this report.
The major players covered in Hemangioma are:
Akrimax
Cutting Edge Laser Technologies
AstraZeneca
Novartis
Pierre Fabre
Pfizer
Among other players domestic and global, Hemangioma market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Hemangioma Market Overview
1.1 Product Overview and Scope of Hemangioma
1.2 Classification of Hemangioma by Type
1.2.1 Global Hemangioma Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hemangioma Revenue Market Share by Type in 2019
1.2.3 Medical Therapy
1.2.4 Laser Therapy
1.2.5 Surgery
1.2.6 Other
1.3 Global Hemangioma Market by Application
1.3.1 Overview: Global Hemangioma Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adult
1.3.3 Child
1.4 Global Hemangioma Market by Regions
1.4.1 Global Hemangioma Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hemangioma (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hemangioma Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hemangioma Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hemangioma Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hemangioma Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hemangioma Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Hemangioma Industry Impact
1.5.1 COVID-19 Potential Implications for the Hemangioma
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Hemangioma
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Akrimax
2.1.1 Akrimax Details
2.1.2 Akrimax Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Akrimax SWOT Analysis
2.1.4 Akrimax Product and Services
2.1.5 Akrimax Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cutting Edge Laser Technologies
2.2.1 Cutting Edge Laser Technologies Details
2.2.2 Cutting Edge Laser Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cutting Edge Laser Technologies SWOT Analysis
2.2.4 Cutting Edge Laser Technologies Product and Services
2.2.5 Cutting Edge Laser Technologies Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pierre Fabre
2.5.1 Pierre Fabre Details
2.5.2 Pierre Fabre Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pierre Fabre SWOT Analysis
2.5.4 Pierre Fabre Product and Services
2.5.5 Pierre Fabre Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Hemangioma Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hemangioma Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hemangioma Players Market Share
3.2.2 Top 10 Hemangioma Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hemangioma Revenue and Market Share by Regions
4.2 North America Hemangioma Revenue and Growth Rate (2015-2020)
4.3 Europe Hemangioma Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hemangioma Revenue and Growth Rate (2015-2020)
4.5 South America Hemangioma Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hemangioma Revenue and Growth Rate (2015-2020)
5 North America Hemangioma Revenue by Countries
5.1 North America Hemangioma Revenue by Countries (2015-2020)
5.2 USA Hemangioma Revenue and Growth Rate (2015-2020)
5.3 Canada Hemangioma Revenue and Growth Rate (2015-2020)
5.4 Mexico Hemangioma Revenue and Growth Rate (2015-2020)
6 Europe Hemangioma Revenue by Countries
6.1 Europe Hemangioma Revenue by Countries (2015-2020)
6.2 Germany Hemangioma Revenue and Growth Rate (2015-2020)
6.3 UK Hemangioma Revenue and Growth Rate (2015-2020)
6.4 France Hemangioma Revenue and Growth Rate (2015-2020)
6.5 Russia Hemangioma Revenue and Growth Rate (2015-2020)
6.6 Italy Hemangioma Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hemangioma Revenue by Countries
7.1 Asia-Pacific Hemangioma Revenue by Countries (2015-2020)
7.2 China Hemangioma Revenue and Growth Rate (2015-2020)
7.3 Japan Hemangioma Revenue and Growth Rate (2015-2020)
7.4 Korea Hemangioma Revenue and Growth Rate (2015-2020)
7.5 India Hemangioma Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hemangioma Revenue and Growth Rate (2015-2020)
8 South America Hemangioma Revenue by Countries
8.1 South America Hemangioma Revenue by Countries (2015-2020)
8.2 Brazil Hemangioma Revenue and Growth Rate (2015-2020)
8.3 Argentina Hemangioma Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hemangioma by Countries
9.1 Middle East & Africa Hemangioma Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hemangioma Revenue and Growth Rate (2015-2020)
9.3 UAE Hemangioma Revenue and Growth Rate (2015-2020)
9.4 Egypt Hemangioma Revenue and Growth Rate (2015-2020)
9.5 South Africa Hemangioma Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hemangioma Revenue and Market Share by Type (2015-2020)
10.2 Global Hemangioma Market Forecast by Type (2019-2024)
10.3 Medical Therapy Revenue Growth Rate (2015-2025)
10.4 Laser Therapy Revenue Growth Rate (2015-2025)
10.5 Surgery Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Hemangioma Market Segment by Application
11.1 Global Hemangioma Revenue Market Share by Application (2015-2020)
11.2 Hemangioma Market Forecast by Application (2019-2024)
11.3 Adult Revenue Growth (2015-2020)
11.4 Child Revenue Growth (2015-2020)
12 Global Hemangioma Market Size Forecast (2021-2025)
12.1 Global Hemangioma Market Size Forecast (2021-2025)
12.2 Global Hemangioma Market Forecast by Regions (2021-2025)
12.3 North America Hemangioma Revenue Market Forecast (2021-2025)
12.4 Europe Hemangioma Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hemangioma Revenue Market Forecast (2021-2025)
12.6 South America Hemangioma Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hemangioma Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hemangioma Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hemangioma by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hemangioma Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hemangioma Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Hemangioma Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Akrimax Corporate Information, Location and Competitors
Table 7. Akrimax Hemangioma Major Business
Table 8. Akrimax Hemangioma Total Revenue (USD Million) (2017-2018)
Table 9. Akrimax SWOT Analysis
Table 10. Akrimax Hemangioma Product and Solutions
Table 11. Akrimax Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Cutting Edge Laser Technologies Corporate Information, Location and Competitors
Table 13. Cutting Edge Laser Technologies Hemangioma Major Business
Table 14. Cutting Edge Laser Technologies Hemangioma Total Revenue (USD Million) (2018-2019)
Table 15. Cutting Edge Laser Technologies SWOT Analysis
Table 16. Cutting Edge Laser Technologies Hemangioma Product and Solutions
Table 17. Cutting Edge Laser Technologies Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. AstraZeneca Corporate Information, Location and Competitors
Table 19. AstraZeneca Hemangioma Major Business
Table 20. AstraZeneca Hemangioma Total Revenue (USD Million) (2017-2018)
Table 21. AstraZeneca SWOT Analysis
Table 22. AstraZeneca Hemangioma Product and Solutions
Table 23. AstraZeneca Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Novartis Corporate Information, Location and Competitors
Table 25. Novartis Hemangioma Major Business
Table 26. Novartis Hemangioma Total Revenue (USD Million) (2017-2018)
Table 27. Novartis SWOT Analysis
Table 28. Novartis Hemangioma Product and Solutions
Table 29. Novartis Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Pierre Fabre Corporate Information, Location and Competitors
Table 31. Pierre Fabre Hemangioma Major Business
Table 32. Pierre Fabre Hemangioma Total Revenue (USD Million) (2017-2018)
Table 33. Pierre Fabre SWOT Analysis
Table 34. Pierre Fabre Hemangioma Product and Solutions
Table 35. Pierre Fabre Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pfizer Corporate Information, Location and Competitors
Table 37. Pfizer Hemangioma Major Business
Table 38. Pfizer Hemangioma Total Revenue (USD Million) (2017-2018)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Hemangioma Product and Solutions
Table 41. Pfizer Hemangioma Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Hemangioma Revenue (Million USD) by Players (2015-2020)
Table 43. Global Hemangioma Revenue Share by Players (2015-2020)
Table 44. Global Hemangioma Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Hemangioma Revenue Market Share by Regions (2015-2020)
Table 46. North America Hemangioma Revenue by Countries (2015-2020)
Table 47. North America Hemangioma Revenue Market Share by Countries (2015-2020)
Table 48. Europe Hemangioma Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Hemangioma Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Hemangioma Revenue by Countries (2015-2020)
Table 51. South America Hemangioma Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Hemangioma Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Hemangioma Revenue Market Share by Countries (2015-2020)
Table 54. Global Hemangioma Revenue (Million USD) by Type (2015-2020)
Table 55. Global Hemangioma Revenue Share by Type (2015-2020)
Table 56. Global Hemangioma Revenue Forecast by Type (2021-2025)
Table 57. Global Hemangioma Revenue by Application (2015-2020)
Table 58. Global Hemangioma Revenue Share by Application (2015-2020)
Table 59. Global Hemangioma Revenue Forecast by Application (2021-2025)
Table 60. Global Hemangioma Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hemangioma Picture
Figure 2. Global Hemangioma Revenue Market Share by Type in 2019
Figure 3. Medical Therapy Picture
Figure 4. Laser Therapy Picture
Figure 5. Surgery Picture
Figure 6. Other Picture
Figure 7. Hemangioma Revenue Market Share by Application in 2019
Figure 8. Adult Picture
Figure 9. Child Picture
Figure 10. Global Hemangioma Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hemangioma Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Hemangioma Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Hemangioma Revenue Market Share in 2019
Figure 19. Global Top 10 Players Hemangioma Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Hemangioma Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Hemangioma Revenue Market Share by Regions (2015-2020)
Figure 23. Global Hemangioma Revenue Market Share by Regions in 2018
Figure 24. North America Hemangioma Revenue and Growth Rate (2015-2020)
Figure 25. Europe Hemangioma Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Hemangioma Revenue and Growth Rate (2015-2020)
Figure 27. South America Hemangioma Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Hemangioma Revenue and Growth Rate (2015-2020)
Figure 29. North America Hemangioma Revenue Market Share by Countries (2015-2020)
Figure 30. North America Hemangioma Revenue Market Share by Countries in 2019
Figure 31. USA Hemangioma Revenue and Growth Rate (2015-2020)
Figure 32. Canada Hemangioma Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Hemangioma Revenue and Growth Rate (2015-2020)
Figure 34. Europe Hemangioma Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Hemangioma Revenue Market Share by Countries in 2019
Figure 36. Germany Hemangioma Revenue and Growth Rate (2015-2020)
Figure 37. UK Hemangioma Revenue and Growth Rate (2015-2020)
Figure 38. France Hemangioma Revenue and Growth Rate (2015-2020)
Figure 39. Russia Hemangioma Revenue and Growth Rate (2015-2020)
Figure 40. Italy Hemangioma Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Hemangioma Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Hemangioma Revenue Market Share by Countries in 2019
Figure 43. China Hemangioma Revenue and Growth Rate (2015-2020)
Figure 44. Japan Hemangioma Revenue and Growth Rate (2015-2020)
Figure 45. Korea Hemangioma Revenue and Growth Rate (2015-2020)
Figure 46. India Hemangioma Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Hemangioma Revenue and Growth Rate (2015-2020)
Figure 48. South America Hemangioma Revenue Market Share by Countries (2015-2020)
Figure 49. South America Hemangioma Revenue Market Share by Countries in 2019
Figure 50. Brazil Hemangioma Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Hemangioma Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Hemangioma Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Hemangioma Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Hemangioma Revenue and Growth Rate (2015-2020)
Figure 55. UAE Hemangioma Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Hemangioma Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Hemangioma Revenue and Growth Rate (2015-2020)
Figure 58. Global Hemangioma Revenue Share by Type (2015-2020)
Figure 59. Global Hemangioma Revenue Share by Type in 2019
Figure 60. Global Hemangioma Market Share Forecast by Type (2021-2025)
Figure 61. Global Medical Therapy Revenue Growth Rate (2015-2020)
Figure 62. Global Laser Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Surgery Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Hemangioma Revenue Share by Application (2015-2020)
Figure 66. Global Hemangioma Revenue Share by Application in 2019
Figure 67. Global Hemangioma Market Share Forecast by Application (2021-2025)
Figure 68. Global Adult Revenue Growth Rate (2015-2020)
Figure 69. Global Child Revenue Growth Rate (2015-2020)
Figure 70. Global Hemangioma Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Hemangioma Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Hemangioma Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Hemangioma Revenue Market Forecast (2021-2025)
Figure 74. Europe Hemangioma Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Hemangioma Revenue Market Forecast (2021-2025)
Figure 76. South America Hemangioma Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Hemangioma Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
高強度レーザー治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The High Intensity Laser Therapy Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- 高強度集束超音波（HIFU）療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global High Intensity Focused Ultrasound (HIFU) Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 16.9% in the forecast period of 2020 to 2025 and will expected to reach USD 159.2 million by 2025, from USD 85 million in 2…
- 磁気治療器具の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Magnetic Therapy Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 圧迫療法装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Compression Therapy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Compression Thera…
- 心臓再同期療法（CRT）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cardiac Resynchronization Therapy (CRT) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 5790.2 million by 2025, from USD 4895.2 million in 2019. …